As noted above, Aerts et al [18] reported that in established RA the peripheral Th17 cell frequency is not elevated, but anti-TNF therapy induces a striking increase of circulating Th17 cells and IL-17 production, irrespective of disease activity. Here, IL17A is linked to rheumatoid arthritis.